COVID-19: uma abordagem médico-conservacionista
Palavras-chave:
Pandemia, SARS-CoV-2, Medicina da Conservação, Impacto Ambiental, Salto Interespecífico
Resumo
Desde o final de 2019, na China, um novo coronavírus passou a provocar síndrome respiratória aguda grave (SARS) que se espalhou pelo mundo e estabeleceu uma pandemia. O surto já acometeu milhões de pessoas, gerou centenas de milhares de mortes e trouxe prejuízo econômico que pode alcançar trilhões de dólares. Vírus como o agente da COVID-19 passam a infectar o homem por episódios de salto da barreira interespecífica, passando por uma ou mais espécies. Assim, a contaminação inicial depende do contato com a vida selvagem, o que se torna cada vez mais comum com a hiperexploração de espécies, a destruição de habitats e o aumento populacional. O estudo desse fluxo de agentes infecciosos, relacionando a medicina humana à sanidade animal e às questões ambientais é feito pela Medicina da Conservação. A partir de pesquisa exploratória, analisou-se a COVID-19 através da perspectiva médico-conservacionais e mostrou-se que intervenções na origem dos agentes infecciosos seriam capazes de restringir surtos devastadores de doenças e, consequentemente, reduzir impactos sociais e econômicos.
Referências
ALDERS, R. Conservation medicine. Environment Science and Policy for Sustainable Development, [S. l.], v. 51, n. 4, p. 7-8, 2009.
ALEGADO, S. Global cost of coronavirus may reach $ 4.1 trillion, ADBsays. Bloomberg, [S. l.], 2020. Disponível em: https://www.bloomberg.com/news/articles/2020-04-03/global-cost-of-coronavirus-could-reach-4-1-trillion-adb-says. Acesso em: 22 abr. 2020.
ALMEIDA, J. D. et al. Virology: coronavirus. Nature, [S. l.], v. 220, p. 650, 1968.
ANDERSEN, G. A. et al. The proximal origin of SARS-CoV-2. Nature Medicine, [S. l.], v. 26, p. 450-452, 2020. DOI 10.1038/s41591-020-0820-9. Disponível em: https://www.nature.com/articles/s41591-020-0820-9. Acesso em: 1 abr. 2020.
BAKER, Tim; MACDONALD, Laurie. Investing in nature: the economic benefits of conserving natural areas in northeast Florida. Washington: Defenders of Wildlife, 2004. Disponível em: https://defenders.org/sites/default/files/publications/investing_in_nature.pdf. Acesso em: 28 abr. 2020.
BLOOM, D. E.; CARDARETTE, D.; SEVILLA, J. P. The economic risks and impacts of epidemics. F&D Magazine, [S. l.], v. 55, n. 2, p. 46-49, 2018.
BRANN, David H. et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. BioRxiv, [S. l.], p. 1-51, 2020. DOI 10.1101/2020.03.25.009084. Disponível em: https://www.biorxiv.org/content/10.1101/2020.03.25.009084v4. Acesso em: 22 abr. 2020.
BRASIL. Lei nº 9.605, de 12 de fevereiro de 1998. Dispõe sobre as sanções penais e administrativas derivadas de condutas e atividades lesivas ao meio ambiente, e dá outras providências. Brasília, DF: Presidência da República, 1998.
BRASIL. Ministério da Saúde. Boletim epidemiológico: identificação de um caso de febre hemorrágica brasileira no estado de São Paulo, Janeiro de 2020. Brasília, DF: Secretaria de Vigilância em Saúde, 2020. Disponível em: http://saude.gov.br/images/pdf/2020/janeiro/20/Boletim-epidemiologico-SVS-03.pdf. Acesso em: 25 abr. 2020.
CAI, J. et al. Indirect virus transmission in cluster of COVID-19 cases, Wenzhou, China, 2020. Emerging Infectious Diseases, [S. l.], v. 26, n. 6, p. 1343-1345, 2020. DOI 10.3201/eid2606.200412. Disponível em: https://wwwnc.cdc.gov/eid/article/26/6/20-0412_article. Acesso em: 22 abr. 2020.
CASADEVALL, A.; PIROFSKI, L. The convalescent sera option for containing COVID-19. The Journal of Clinical Investigation, [S. l.], v. 130, n. 4, p. 1545–1548, 2020. DOI 10.1172/JCI138003. Disponível em: https://www.jci.org/articles/view/138003. Acesso em: 22 abr. 2020.
CHAN, J. F. W. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet, [S. l.], v. 395, p. 514-523, 2020. DOI 10.1016/S0140-6736(20)30154-9. Disponível em: https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(20)30154-9.pdf. Acesso em: 22 abr. 2020.
CUI, J.; LI, F.; SHI, Z. L. Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology, [S. l.], v. 17, p. 181–92, 2019.
CUNNINGHAM, A. A.; DASZAK, P.; WOOD, J. L. N. One health, emerging infectious diseases and wildlife: two decades of progress? Philosophical Transactions of the Royal Society B: Biological Sciences, [S. l.], v. 372, n. 1725, 2017. DOI 10.1098/rstb.2016.0167. Disponível em: https://royalsocietypublishing.org/doi/10.1098/rstb.2016.0167. Acesso em: 22 abr. 2020.
DASZAK, P. et al. Conservation medicine and a new agenda for emerging diseases. Annals of the New York Academy of Sciences, [S. l.], v. 1026, p. 1-11, 2004. DOI 10.1196/annals.1307.001. Disponível em: https://nyaspubs.onlinelibrary.wiley.com/doi/full/10.1196/annals.1307.001. Acesso em: 22 abr. 2020.
DELIVORIAS, A.; SCHOLZ, N. Economic impact of epidemics and pandemics. [Bruxelas]: EPRS, 2020. Disponível em: https://www.europarl.europa.eu/RegData/etudes/BRIE/2020/646195/EPRS_BRI(2020)646195_EN.pdf. Acesso em: 22 abr. 2020.
DENIS, M.; VANDEWEERD, V.; VAN DER VLIET, D. Overview of information available to support the development of medical countermeasures and interventions against COVID-19. Transdisciplinary Insights - Living Paper, [S. l.], p. 1-120, 2020. Disponível em: https://www.apfh.pt/xfiles/scContentDeployer_pt/links/link92.pdf. Acesso em: 22 abr. 2020.
FAN, V. Y.; JAMISON, D. T.; SUMMERS, L. H. Pandemic risk: how large are the expected losses? Bulletin of the World Health Organization, [S. l.], n. 96, p. 129–134, 2018.
FENG, Z. et al. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19). China CDC Weekly, [S. l.], v. 2, n. 8, p. 113-122, 2020. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32064853/. Acesso em: 22 abr. 2020.
GARRIDO, R. G.; GARRIDO, F. S. R. G. COVID-19: um panorama com ênfase em medidas restritivas de contato interpessoal. Interfaces Científicas - Saúde e Ambiente, [S. l.], v. 8, p. 127-141, 2020.
GE, X. Y. et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature, [S. l.], v. 503, n. 7477, p. 535–538, 2013.
GONZÁLEZ, J.M, et al. A comparative sequence analysis to revise the current taxonomy of the family coronaviridae. Archives of Virology, [S. l.], v. 148, n. 11, p. 2207-2235, 2001.
GORBALENYA, A. E. et al. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology, [S. l.], v. 5, p. 536–544, 2020. DOI 10.1038/s41564-020-0695-z. Disponível em: https://www.nature.com/articles/s41564-020-0695-z. Acesso em: 1 abr. 2020.
GUAN, Y. et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science, [S. l.], v. 302, n. 5643, p. 276-278, 2003. Disponível em: https://science.sciencemag.org/content/302/5643/276. Acesso em: 22 abr. 2020.
INTERNATIONAL COMMITTEE ON TAXONOMY OF VIRUSES. News. [S. l.], 2020. Disponível em: https://talk.ictvonline.org/. Acesso em: 1 abr. 2020.
JONES, K. E. et al. Global trends in emerging infectious diseases. Nature, [S. l.], v. 451, n. 7181, p. 990-993, 2008.
KAKODKAR, P.; KAKA, N.; BAIG, M. N. A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19). Cureus, [S. l.], v. 12, n. 4, p. 1-18, 2020. DOI 10.7759/cureus.7560. Disponível em: https://www.cureus.com/articles/29670-a-comprehensive-literature-review-on-the-clinical-presentation-and-management-of-the-pandemic-coronavirus-disease-2019-covid-19. Acesso em: 22 abr. 2020.
KAMPF, G. et al. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. The Journal of Hospital Infection, [S. l.], v. 104, n. 3, p. 246-251, 2020. DOI 10.1016/j.jhin.2020.01.022. Disponível em: https://www.journalofhospitalinfection.com/article/S0195-6701(20)30046-3/fulltext. Acesso em: 22 abr. 2020.
KLENK, H. D. et al. Host cell proteases controlling virus pathogenicity. Trends in Microbiology, [S. l.], v. 2, p. 39-43, 1994.
LEE, G. O. M.; WARNER, M. The impact of SARS on China’s human resources: implications for the labour market and level of unemployment in the service sector in Beijing, Guangzhou and Shanghai. The International Journal of Human Resource Management, [S. l.], v. 17, p. 860–880, 2006. DOI 10.1080/09585190600640919. Disponível em: https://www.tandfonline.com/doi/full/10.1080/09585190600640919. Acesso em: 22 abr. 2020.
LI, Q. et al. A simple laboratory parameter facilitates early identification of COVID-19 patients. MedRxiv, [S. l.], p. 1-6, 2020. DOI 10.1101/2020.02.13.20022830. Disponível em: https://www.medrxiv.org/content/10.1101/2020.02.13.20022830v1. Acesso em: 22 abr. 2020.
LI, W. et al. Bats are natural reservoirs of SARS-like coronaviruses. Science, [S. l.], v. 310, n. 5748, p. 676–679, 2005. DOI 10.1126/science.1118391. Disponível em: https://science.sciencemag.org/content/310/5748/676. Acesso em: 22 abr. 2020.
LIU, Y. et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci, [S. l.], v.63, n. 3, p. 364-374, 2020. DOI 10.1007/s11427-020-1643-8. Disponível em: https://link.springer.com/article/10.1007/s11427-020-1643-8. Acesso em: 22 abr. 2020.
LU, H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). BioScience Trends, [S. l.], v. 14, n. 1, p. 69-71, 2020. DOI 10.5582/bst.2020.01020. Disponível em: https://www.jstage.jst.go.jp/article/bst/14/1/14_2020.01020/_article. Acesso em: 22 abr. 2020.
LWCF. Return on the investment from the land and water conservation fund: a report by the trust for public land. Boston: The Trust for Public Land, 2010. Disponível em: http://cloud.tpl.org/pubs/benefits-LWCF-ROI%20Report-11-2010.pdf. Acesso em: 28 abr. 2020.
MCINTOSH, K. Coronaviruses: a comparative review. Current Topics in Microbiology and Immunology, [S. l.], v. 63, p. 85-129, 1974.
NEGRI, E. M. et al. Heparin therapy improving hypoxia in COVID-19 patients - a case series. MedRxiv, [S. l.], p. 1-15, 2020. DOI 2020.04.15.20067017. Disponível em: https://www.medrxiv.org/content/10.1101/2020.04.15.20067017v3. Acesso em: 22 abr. 2020.
NOVEL CORONAVIRUS PNEUMONIA EMERGENCY RESPONSE EPIDEMIOLOGY TEAM. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chin J Epidemiol, [S. l.], v. 41, n. 2, p. 145-151, 2020.
PIKE, J. et al. Economic optimization of a global strategy to reduce the pandemic threat. PNAS, [S. l.], v. 111, n. 52, p. 18519–18523, 2014. DOI 10.1073/pnas.1412661112. Disponível em: https://www.pnas.org/content/111/52/18519. Acesso em: 22 abr. 2020.
QIU, W. et al. The impacts on health, society, and economy of SARS and H7N9 outbreaks in China: a case comparison study. Journal of Environmental and Public Health, [S. l.], p. 1-8, 2018. DOI 10.1155/2018/2710185. Disponível em: https://www.hindawi.com/journals/jeph/2018/2710185/. Acesso em: 22 abr. 2020.
SANDS, P. et al. Assessment of economic vulnerability to infectious disease crises. The Lancet, [S. l.], v. 388, p. 2443–2448, 2016. DOI 10.1016/S0140-6736(16)30594-3. Disponível em: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)30594-3/fulltext. Acesso em: 22 abr. 2020.
SILVEIRA, J. A. G.; D'ELIA, M. L. Medicina da conservação: a ciência da saúde do ecossistema. Cadernos Técnicos de Veterinária e Zootecnia (UFMG), Minas Gerais, v. 72, p. 16-27, 2014.
SMITH, R. D. Responding to global infectious disease outbreaks: lessons from SARS on the role of risk perception, communication and management. Social Science & Medicine, [S. l.], v. 63, n. 12, p. 3113–3123, 2006. DOI 10.1016/j.socscimed.2006.08.004. Disponível em: https://www.sciencedirect.com/science/article/pii/S0277953606004060?via%3Dihub. Acesso em: 1 abr. 2020.
STEINHAUER, D. A. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology, [S. l.], v. 258, p. 1-20, 1999.
TAN, W. et al. Notes from the field: a novel coronavirus genome identified in a cluster of pneumonia cases—Wuhan, China 2019-2020. China CDC Weekly, [S. l.], v. 2, n. 4, p. 61-62, 2020.
UNDP. A socio-economic impact assessment of the Zika Virus in Latin America and the caribbean: with a focus on Brazil, Colombia and Suriname. New York: UNDP, 2017. Disponível em: https://www.undp.org/content/dam/rblac/docs/Research%20and%20Publications/HIV/UNDP-RBLAC-Zika-English-WEB.pdf. Acesso em: 28 abr. 2020.
VAN DOREMALEN, N. et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New England Journal of Medicine, [S. l.], v. 16, n. 382, p. 1564-1567, 2020. DOI 10.1056/NEJMc2004973. Disponível em: https://www.nejm.org/doi/10.1056/NEJMc2004973. Acesso em: 22 abr. 2020.
WALLS, A. C. et al. Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein. BioRxiv, [S. l.], p. 1-34, 2020. DOI 10.1101/2020.02.19.956581. Disponível em: https://www.biorxiv.org/content/10.1101/2020.02.19.956581v1. Acesso em: 1 abr. 2020.
WAN, Y. et al. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. Journal of Virology, [S. l.], v. 94, n. 7, 2020. DOI 10.1128/JVI.00127-20. Disponível em: https://jvi.asm.org/content/94/7/e00127-20. Acesso em: 1 abr. 2020.
WANG, N. et al. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Research, [S. l.], v. 23, n. 8, p. 986-93, 2013. DOI 10.1038/cr.2013.92. Disponível em: https://www.nature.com/articles/cr201392. Acesso em: 1 abr. 2020.
WEISS, S. R.; NAVAS-MARTIN, S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiology and Molecular Biology Reviews, [S. l.], v. 9, n. 4, p. 635–664, 2005.
WHO. Coronavirus disease (COVID-19): situation report – 122. [Genebra]: WHO, 2020a. Disponível em: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200521-covid-19-sitrep-122.pdf?sfvrsn=24f20e05_2. Acesso em: 22 maio 2020.
WHO. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Geneva: WHO, 2020b. Disponível em: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov). Acesso em: 25 mar. 2020.
WHO. DRAFT landscape of COVID-19 candidate vaccines – 20 April 2020. [Genebra]: WHO, 2020c. Disponível em: https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1. Acesso em: 25 mar. 2020.
WORLD BANK GROUP. Pandemic emergency financing facility. [S. l.], 2019. Disponível em: https://www.worldbank.org/en/topic/pandemics/brief/pandemic-emergency-financing-facility?cid=EXT_WBSocialShare_EXT. Acesso em: 25 abr. 2020.
WRAPP, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science, [S. l.], v. 367, n. 6483, p. 1260-1263, 2020.
WU, Y. et al. SARS-CoV-2 is an appropriate name for the new coronavirus. The Lancet, [S. l.], v. 395, n. 10228, p. 949-950, 2020. Disponível em: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30557-2/fulltext. Acesso em: 22 abr. 2020.
YAO, H. et al. Patient-derived mutations impact pathogenicity of SARS-CoV-2. MedRxiv, [S. l.], p. 1-57, 2020. DOI 10.1101/2020.04.14.20060160. Disponível em: https://www.medrxiv.org/content/10.1101/2020.04.14.20060160v2. Acesso em: 22 abr. 2020.
ZHOU, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, [S. l.], v. 579, p. 270–273, 2020.
ALEGADO, S. Global cost of coronavirus may reach $ 4.1 trillion, ADBsays. Bloomberg, [S. l.], 2020. Disponível em: https://www.bloomberg.com/news/articles/2020-04-03/global-cost-of-coronavirus-could-reach-4-1-trillion-adb-says. Acesso em: 22 abr. 2020.
ALMEIDA, J. D. et al. Virology: coronavirus. Nature, [S. l.], v. 220, p. 650, 1968.
ANDERSEN, G. A. et al. The proximal origin of SARS-CoV-2. Nature Medicine, [S. l.], v. 26, p. 450-452, 2020. DOI 10.1038/s41591-020-0820-9. Disponível em: https://www.nature.com/articles/s41591-020-0820-9. Acesso em: 1 abr. 2020.
BAKER, Tim; MACDONALD, Laurie. Investing in nature: the economic benefits of conserving natural areas in northeast Florida. Washington: Defenders of Wildlife, 2004. Disponível em: https://defenders.org/sites/default/files/publications/investing_in_nature.pdf. Acesso em: 28 abr. 2020.
BLOOM, D. E.; CARDARETTE, D.; SEVILLA, J. P. The economic risks and impacts of epidemics. F&D Magazine, [S. l.], v. 55, n. 2, p. 46-49, 2018.
BRANN, David H. et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. BioRxiv, [S. l.], p. 1-51, 2020. DOI 10.1101/2020.03.25.009084. Disponível em: https://www.biorxiv.org/content/10.1101/2020.03.25.009084v4. Acesso em: 22 abr. 2020.
BRASIL. Lei nº 9.605, de 12 de fevereiro de 1998. Dispõe sobre as sanções penais e administrativas derivadas de condutas e atividades lesivas ao meio ambiente, e dá outras providências. Brasília, DF: Presidência da República, 1998.
BRASIL. Ministério da Saúde. Boletim epidemiológico: identificação de um caso de febre hemorrágica brasileira no estado de São Paulo, Janeiro de 2020. Brasília, DF: Secretaria de Vigilância em Saúde, 2020. Disponível em: http://saude.gov.br/images/pdf/2020/janeiro/20/Boletim-epidemiologico-SVS-03.pdf. Acesso em: 25 abr. 2020.
CAI, J. et al. Indirect virus transmission in cluster of COVID-19 cases, Wenzhou, China, 2020. Emerging Infectious Diseases, [S. l.], v. 26, n. 6, p. 1343-1345, 2020. DOI 10.3201/eid2606.200412. Disponível em: https://wwwnc.cdc.gov/eid/article/26/6/20-0412_article. Acesso em: 22 abr. 2020.
CASADEVALL, A.; PIROFSKI, L. The convalescent sera option for containing COVID-19. The Journal of Clinical Investigation, [S. l.], v. 130, n. 4, p. 1545–1548, 2020. DOI 10.1172/JCI138003. Disponível em: https://www.jci.org/articles/view/138003. Acesso em: 22 abr. 2020.
CHAN, J. F. W. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet, [S. l.], v. 395, p. 514-523, 2020. DOI 10.1016/S0140-6736(20)30154-9. Disponível em: https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(20)30154-9.pdf. Acesso em: 22 abr. 2020.
CUI, J.; LI, F.; SHI, Z. L. Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology, [S. l.], v. 17, p. 181–92, 2019.
CUNNINGHAM, A. A.; DASZAK, P.; WOOD, J. L. N. One health, emerging infectious diseases and wildlife: two decades of progress? Philosophical Transactions of the Royal Society B: Biological Sciences, [S. l.], v. 372, n. 1725, 2017. DOI 10.1098/rstb.2016.0167. Disponível em: https://royalsocietypublishing.org/doi/10.1098/rstb.2016.0167. Acesso em: 22 abr. 2020.
DASZAK, P. et al. Conservation medicine and a new agenda for emerging diseases. Annals of the New York Academy of Sciences, [S. l.], v. 1026, p. 1-11, 2004. DOI 10.1196/annals.1307.001. Disponível em: https://nyaspubs.onlinelibrary.wiley.com/doi/full/10.1196/annals.1307.001. Acesso em: 22 abr. 2020.
DELIVORIAS, A.; SCHOLZ, N. Economic impact of epidemics and pandemics. [Bruxelas]: EPRS, 2020. Disponível em: https://www.europarl.europa.eu/RegData/etudes/BRIE/2020/646195/EPRS_BRI(2020)646195_EN.pdf. Acesso em: 22 abr. 2020.
DENIS, M.; VANDEWEERD, V.; VAN DER VLIET, D. Overview of information available to support the development of medical countermeasures and interventions against COVID-19. Transdisciplinary Insights - Living Paper, [S. l.], p. 1-120, 2020. Disponível em: https://www.apfh.pt/xfiles/scContentDeployer_pt/links/link92.pdf. Acesso em: 22 abr. 2020.
FAN, V. Y.; JAMISON, D. T.; SUMMERS, L. H. Pandemic risk: how large are the expected losses? Bulletin of the World Health Organization, [S. l.], n. 96, p. 129–134, 2018.
FENG, Z. et al. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19). China CDC Weekly, [S. l.], v. 2, n. 8, p. 113-122, 2020. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32064853/. Acesso em: 22 abr. 2020.
GARRIDO, R. G.; GARRIDO, F. S. R. G. COVID-19: um panorama com ênfase em medidas restritivas de contato interpessoal. Interfaces Científicas - Saúde e Ambiente, [S. l.], v. 8, p. 127-141, 2020.
GE, X. Y. et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature, [S. l.], v. 503, n. 7477, p. 535–538, 2013.
GONZÁLEZ, J.M, et al. A comparative sequence analysis to revise the current taxonomy of the family coronaviridae. Archives of Virology, [S. l.], v. 148, n. 11, p. 2207-2235, 2001.
GORBALENYA, A. E. et al. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology, [S. l.], v. 5, p. 536–544, 2020. DOI 10.1038/s41564-020-0695-z. Disponível em: https://www.nature.com/articles/s41564-020-0695-z. Acesso em: 1 abr. 2020.
GUAN, Y. et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science, [S. l.], v. 302, n. 5643, p. 276-278, 2003. Disponível em: https://science.sciencemag.org/content/302/5643/276. Acesso em: 22 abr. 2020.
INTERNATIONAL COMMITTEE ON TAXONOMY OF VIRUSES. News. [S. l.], 2020. Disponível em: https://talk.ictvonline.org/. Acesso em: 1 abr. 2020.
JONES, K. E. et al. Global trends in emerging infectious diseases. Nature, [S. l.], v. 451, n. 7181, p. 990-993, 2008.
KAKODKAR, P.; KAKA, N.; BAIG, M. N. A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19). Cureus, [S. l.], v. 12, n. 4, p. 1-18, 2020. DOI 10.7759/cureus.7560. Disponível em: https://www.cureus.com/articles/29670-a-comprehensive-literature-review-on-the-clinical-presentation-and-management-of-the-pandemic-coronavirus-disease-2019-covid-19. Acesso em: 22 abr. 2020.
KAMPF, G. et al. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. The Journal of Hospital Infection, [S. l.], v. 104, n. 3, p. 246-251, 2020. DOI 10.1016/j.jhin.2020.01.022. Disponível em: https://www.journalofhospitalinfection.com/article/S0195-6701(20)30046-3/fulltext. Acesso em: 22 abr. 2020.
KLENK, H. D. et al. Host cell proteases controlling virus pathogenicity. Trends in Microbiology, [S. l.], v. 2, p. 39-43, 1994.
LEE, G. O. M.; WARNER, M. The impact of SARS on China’s human resources: implications for the labour market and level of unemployment in the service sector in Beijing, Guangzhou and Shanghai. The International Journal of Human Resource Management, [S. l.], v. 17, p. 860–880, 2006. DOI 10.1080/09585190600640919. Disponível em: https://www.tandfonline.com/doi/full/10.1080/09585190600640919. Acesso em: 22 abr. 2020.
LI, Q. et al. A simple laboratory parameter facilitates early identification of COVID-19 patients. MedRxiv, [S. l.], p. 1-6, 2020. DOI 10.1101/2020.02.13.20022830. Disponível em: https://www.medrxiv.org/content/10.1101/2020.02.13.20022830v1. Acesso em: 22 abr. 2020.
LI, W. et al. Bats are natural reservoirs of SARS-like coronaviruses. Science, [S. l.], v. 310, n. 5748, p. 676–679, 2005. DOI 10.1126/science.1118391. Disponível em: https://science.sciencemag.org/content/310/5748/676. Acesso em: 22 abr. 2020.
LIU, Y. et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci, [S. l.], v.63, n. 3, p. 364-374, 2020. DOI 10.1007/s11427-020-1643-8. Disponível em: https://link.springer.com/article/10.1007/s11427-020-1643-8. Acesso em: 22 abr. 2020.
LU, H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). BioScience Trends, [S. l.], v. 14, n. 1, p. 69-71, 2020. DOI 10.5582/bst.2020.01020. Disponível em: https://www.jstage.jst.go.jp/article/bst/14/1/14_2020.01020/_article. Acesso em: 22 abr. 2020.
LWCF. Return on the investment from the land and water conservation fund: a report by the trust for public land. Boston: The Trust for Public Land, 2010. Disponível em: http://cloud.tpl.org/pubs/benefits-LWCF-ROI%20Report-11-2010.pdf. Acesso em: 28 abr. 2020.
MCINTOSH, K. Coronaviruses: a comparative review. Current Topics in Microbiology and Immunology, [S. l.], v. 63, p. 85-129, 1974.
NEGRI, E. M. et al. Heparin therapy improving hypoxia in COVID-19 patients - a case series. MedRxiv, [S. l.], p. 1-15, 2020. DOI 2020.04.15.20067017. Disponível em: https://www.medrxiv.org/content/10.1101/2020.04.15.20067017v3. Acesso em: 22 abr. 2020.
NOVEL CORONAVIRUS PNEUMONIA EMERGENCY RESPONSE EPIDEMIOLOGY TEAM. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chin J Epidemiol, [S. l.], v. 41, n. 2, p. 145-151, 2020.
PIKE, J. et al. Economic optimization of a global strategy to reduce the pandemic threat. PNAS, [S. l.], v. 111, n. 52, p. 18519–18523, 2014. DOI 10.1073/pnas.1412661112. Disponível em: https://www.pnas.org/content/111/52/18519. Acesso em: 22 abr. 2020.
QIU, W. et al. The impacts on health, society, and economy of SARS and H7N9 outbreaks in China: a case comparison study. Journal of Environmental and Public Health, [S. l.], p. 1-8, 2018. DOI 10.1155/2018/2710185. Disponível em: https://www.hindawi.com/journals/jeph/2018/2710185/. Acesso em: 22 abr. 2020.
SANDS, P. et al. Assessment of economic vulnerability to infectious disease crises. The Lancet, [S. l.], v. 388, p. 2443–2448, 2016. DOI 10.1016/S0140-6736(16)30594-3. Disponível em: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)30594-3/fulltext. Acesso em: 22 abr. 2020.
SILVEIRA, J. A. G.; D'ELIA, M. L. Medicina da conservação: a ciência da saúde do ecossistema. Cadernos Técnicos de Veterinária e Zootecnia (UFMG), Minas Gerais, v. 72, p. 16-27, 2014.
SMITH, R. D. Responding to global infectious disease outbreaks: lessons from SARS on the role of risk perception, communication and management. Social Science & Medicine, [S. l.], v. 63, n. 12, p. 3113–3123, 2006. DOI 10.1016/j.socscimed.2006.08.004. Disponível em: https://www.sciencedirect.com/science/article/pii/S0277953606004060?via%3Dihub. Acesso em: 1 abr. 2020.
STEINHAUER, D. A. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology, [S. l.], v. 258, p. 1-20, 1999.
TAN, W. et al. Notes from the field: a novel coronavirus genome identified in a cluster of pneumonia cases—Wuhan, China 2019-2020. China CDC Weekly, [S. l.], v. 2, n. 4, p. 61-62, 2020.
UNDP. A socio-economic impact assessment of the Zika Virus in Latin America and the caribbean: with a focus on Brazil, Colombia and Suriname. New York: UNDP, 2017. Disponível em: https://www.undp.org/content/dam/rblac/docs/Research%20and%20Publications/HIV/UNDP-RBLAC-Zika-English-WEB.pdf. Acesso em: 28 abr. 2020.
VAN DOREMALEN, N. et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New England Journal of Medicine, [S. l.], v. 16, n. 382, p. 1564-1567, 2020. DOI 10.1056/NEJMc2004973. Disponível em: https://www.nejm.org/doi/10.1056/NEJMc2004973. Acesso em: 22 abr. 2020.
WALLS, A. C. et al. Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein. BioRxiv, [S. l.], p. 1-34, 2020. DOI 10.1101/2020.02.19.956581. Disponível em: https://www.biorxiv.org/content/10.1101/2020.02.19.956581v1. Acesso em: 1 abr. 2020.
WAN, Y. et al. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. Journal of Virology, [S. l.], v. 94, n. 7, 2020. DOI 10.1128/JVI.00127-20. Disponível em: https://jvi.asm.org/content/94/7/e00127-20. Acesso em: 1 abr. 2020.
WANG, N. et al. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Research, [S. l.], v. 23, n. 8, p. 986-93, 2013. DOI 10.1038/cr.2013.92. Disponível em: https://www.nature.com/articles/cr201392. Acesso em: 1 abr. 2020.
WEISS, S. R.; NAVAS-MARTIN, S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiology and Molecular Biology Reviews, [S. l.], v. 9, n. 4, p. 635–664, 2005.
WHO. Coronavirus disease (COVID-19): situation report – 122. [Genebra]: WHO, 2020a. Disponível em: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200521-covid-19-sitrep-122.pdf?sfvrsn=24f20e05_2. Acesso em: 22 maio 2020.
WHO. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Geneva: WHO, 2020b. Disponível em: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov). Acesso em: 25 mar. 2020.
WHO. DRAFT landscape of COVID-19 candidate vaccines – 20 April 2020. [Genebra]: WHO, 2020c. Disponível em: https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1. Acesso em: 25 mar. 2020.
WORLD BANK GROUP. Pandemic emergency financing facility. [S. l.], 2019. Disponível em: https://www.worldbank.org/en/topic/pandemics/brief/pandemic-emergency-financing-facility?cid=EXT_WBSocialShare_EXT. Acesso em: 25 abr. 2020.
WRAPP, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science, [S. l.], v. 367, n. 6483, p. 1260-1263, 2020.
WU, Y. et al. SARS-CoV-2 is an appropriate name for the new coronavirus. The Lancet, [S. l.], v. 395, n. 10228, p. 949-950, 2020. Disponível em: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30557-2/fulltext. Acesso em: 22 abr. 2020.
YAO, H. et al. Patient-derived mutations impact pathogenicity of SARS-CoV-2. MedRxiv, [S. l.], p. 1-57, 2020. DOI 10.1101/2020.04.14.20060160. Disponível em: https://www.medrxiv.org/content/10.1101/2020.04.14.20060160v2. Acesso em: 22 abr. 2020.
ZHOU, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, [S. l.], v. 579, p. 270–273, 2020.
Publicado
2020-06-03
Como Citar
Garrido, R., & Rodrigues, E. (2020). COVID-19: uma abordagem médico-conservacionista. Revista Augustus, 25(51), 394-411. https://doi.org/https://doi.org/10.15202/1981896.2020v25n51p394
Seção
Artigos em fluxo contínuo
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
O conteúdo dos artigos é de responsabilidade exclusiva do(s) autor(es), que se declaram responsáveis por qualquer reclamação de terceiros quanto a conflitos envolvendo direitos autorais, isentando a Revista Augustus de quaisquer pendências envolvendo suas publicações. A cessão de direitos autorais não acarretará em nenhuma espécie de ônus para a revista.
Os autores de trabalhos aprovados declaram a originalidade, o ineditismo e a atualidade de todo o conteúdo do artigo, mediante a apresentação da referência completa de todas as fontes utilizadas no texto e transferem para a Revista Augustus o direito de normalização, edição e publicação do artigo, de modo inédito e exclusivo por nenhum outro meio. Caso seja verificada a quebra de exclusividade, a submissão será arquivada e os autores serão impedidos de publicar novamente na revista por 5 (cinco) anos, sem prejuízo das ações cíveis/penais previstas em lei.
O autor tem plena ciência de que: a) a submissão poderá ser recusada caso o Conselho Editorial da Revista Augustus não considere pertinente a publicação, por quaisquer motivos, devidamente fundamentados; b) os editores reservam-se o direito de modificar o texto da submissão - sem alteração de conteúdo - para normalizá-lo e adaptá-lo às normas de publicação.É permitida a cópia, total ou parcial, de artigo publicado na Revista Augustus, desde que devidamente citada a fonte, sendo vedado o uso comercial e a produção e distribuição de trabalhos derivados.
